Skip to main content Accesibility Help
×
×
Home

Prevalence of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections in patients presenting to Canadian emergency departments

  • Bjug Borgundvaag (a1) (a2), Wil Ng (a3), Brian Rowe (a4), Kevin Katz (a2) (a3) and on the behalf of EMERGency Department Emerging Infectious Disease Surveillance NeTwork (EMERGENT) Working Group (a4)...
Abstract
Background:

Community-associated methicillin-resistant Staphylococcus aureus (MRSA) is an increasingly common cause of skin and soft tissue infection (SSTI) worldwide. The prevalence of MRSA in SSTIs across Canada has not been well described. Studies in the United States have shown significant geographic variability in the prevalence of MRSA. This study characterizes the geographic prevalence and microbiology of MRSA in patients presenting to Canadian emergency departments with SSTIs.

Methods:

Using a prospective, observational design, we enrolled patients with acute purulent SSTIs presenting to 17 hospital emergency departments and 2 community health centres (spanning 6 Canadian provinces) between July 1, 2008, and April 30, 2009. Eligible patients were those whose wound cultures grew S. aureus. MRSA isolates were characterized by antimicrobial susceptibility testing and pulsed-field gel electrophoresis. All patients were subjected to a structured chart audit, and patients whose wound swabs grew MRSA were contacted by telephone to gather detailed information regarding risk factors for MRSA infection, history of illness, and outcomes.

Results:

Of the 1,353 S. aureus–positive encounters recorded, 431 (32%) grew MRSA and 922 (68%) wounds grew methicillin-susceptible S. aureus. We observed significant variation in both the prevalence of MRSA (11–100%) and the proportion of community-associated strains of MRSA (0– 100%) across our study sites, with a significantly higher prevalence of MRSA in western Canada.

Interpretation:

MRSA continues to emerge across Canada, and the prevalence of MRSA in SSTIs across Canada is variable and higher than previously expected.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Prevalence of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections in patients presenting to Canadian emergency departments
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Prevalence of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections in patients presenting to Canadian emergency departments
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Prevalence of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections in patients presenting to Canadian emergency departments
      Available formats
      ×
Copyright
Corresponding author
Mount Sinai Hospital, 600 University Avenue, Room 206, Toronto, ON M5G 1X5; b.borgundvaag@utoronto.ca
References
Hide All
1.Kock, R, Becker, K, Cookson, B, et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 2010;15:19688.
2.Simor, AE, Gilbert, NL, Gravel, D, et al. Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: National Surveillance and Changing Epidemiology, 1995–2007. Infect Control Hosp Epidemiol 2010;31:348–56, doi:10.1086/651313.
3.Simor, AE, Ofner-Agostini, M, Bryce, E, et al. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ 2001;165:21–6.
4.Simor, AE, Ofner-Agostini, M, Gravel, D, et al. Surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals - a report update from the Canadian Nosocomial Infection Surveillance Program. Can Commun Dis Rep 2005;31:33–9.
5.Grundmann, H, Aires-de-Sousa, M, Boyce, J, et al. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006;368:874–85, doi:10.1016/S0140-6736(06)68853-3.
6.Cosgrove, SE, Qi, Y, Kaye, KS, et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005;26:166–74, doi:10.1086/502522.
7.Huang, SS, Platt, R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003;36:2811–5, doi:10.1086/345955.
8.Barton, M, Hawkes, M, Moore, D, et al. Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA): a perspective for Canadian health care practitioners. Can J Infect Dis Med Microbiol 2006;17(Suppl C):4C-24C.
9.Labandeira-Rey, M, Couzon, F, Boisset, S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007;315:1130–3, doi:10.1126/science.1137165.
10.Naimi, TS, LeDell, KH, Como-Sabetti, K, et al. Comparison of community- and health care-associated methicillinresistant Staphylococcus aureus infection. JAMA 2003;290:2976–84, doi:10.1001/jama.290.22.2976.
11.Popovich, K, Hota, B, Rice, T, et al. Phenotypic prediction rule for community-associated methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007;45:2293–5, doi:10.1128/JCM.00044-07.
12.Gilbert, M, MacDonald, J, Gregson, D, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 2006;175:149–54, doi:10.1503/cmaj.051565.
13.Groom, AV, Wolsey, DH, Naimi, TS, et al. Communityacquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001;286:1201–5, doi:10.1001/jama.286.10.1201.
14.Kaplan, S, Hulten, K, Gonzalez, B, et al. Three-year surveillance of community-acquired Staphylococus aureus infections in children. Clin Infect Dis 2005;40:1785–91, doi:10.1086/430312.
15.Kazakova, SV, Hageman, JC, Matava, M, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005;352:468–75, doi:10.1056/NEJMoa042859.
16.Lee, NE, Taylor, MM, Bancroft, E, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 2005;40:1529–34, doi:10.1086/429827.
17.Main, C, Jayarante, P, Haley, A, et al. Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility. Can J Infect Dis Med Microbiol 2005;16:343–8.
18.Mathews, W, Caperna, J, Barber, R, et al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005;40:155–60, doi:10.1097/01.qai.0000179464.40948.b9.
19.Rosenthal, A, White, D, Churilla, S, et al. Optimal surveillance culture sites for detection of methicillin-resistant Staphylococcus aureus in newborns. J Clin Microbiol 2006;44:4234–6, doi:10.1128/JCM.00860-06.
20.Zinderman, CE, Conner, B, Malakooti, MA, et al. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 2004;10:941–4, doi:10.3201/eid1005.030604.
21.Tenover, FC, Goering, RV. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 2009;64:441–6, doi:10.1093/jac/dkp241.
22.Moran, GJ, Krishnadasan, A, Gorwitz, RJ, et al. Methicillinresistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666–74, doi:10.1056/NEJMoa055356.
23.Ruhe, J, Smith, N, Menon, A, editors. Significance of antibiotic therapy for the treatment of community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections. Interscience Conference on Antimicrobial Agents and Chemotherapy; 2006; San Francisco (CA). American Society for Microbiology.
24.Weibe, KB. Methicillin-resistant S. aureus associated skin and soft tissue infections in a non-urban Canadian emergency department. CJEM 2007;9:198.
25.Adam, HJ, Allen, VG, Currie, A, et al. Comminuty-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors. CJEM 2009;11:439–46.
26.Stenstrom, R, Grafstein, E, Romney, M, et al. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department. CJEM 2009;11:430–8.
27.Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. M100-S17. Wayne (PA): Clinical Laboratory Standards Institute; 2007.
28.National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A7. National Committee for Clinical Laboratory Standards Wayne, PA. 2006.
29.Eltringham, I. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 1997;35:18, doi:10.1016/S0195-6701(97)90162-6.
30.Toma, E, Barriault, D. Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for grampositive cocci. J Clin Microbiol 1995;33:1712–5.
31.Mulvey, MR, Chui, L, Ismail, J, et al. Development of a Canadian standardized protocol for subtyping methicillinresistant Staphylococcus aureus using pulsed-field gel electrophoresis. J Clin Microbiol 2001;39:3481–5, doi:10.1128/JCM.39.10.3481-3485.2001.
32.Oliveira, DC, de Lencastre, H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002;46:2155–61, doi:10.1128/AAC.46.7.2155-2161.2002.
33.Willey, B, Wong, H, Louie, L, et al, editors. Comparison of two strategies for staphylococcal cassette chromosome mec (SCCmec) typing in methicillin-resistant Staphylococcus aureus. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2006 Sept 27–30; San Francisco, CA.
34.Miller, LG, Perdreau-Remington, F, Bayer, AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007;44:471–82, doi:10.1086/511033.
35.Rajendran, PM, Young, D, Maurer, T, et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother 2007;51:4044–8, doi:10.1128/AAC.00377-07.
36.Weese, J, Rousseau, J, Willey, B, et al. Methicillin-resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease. J Vet Intern Med 2006;20:182–6.
37.Kurbis, C, Wylie, J. Community-based cluster of methicillinresistant Staphylococcus aureus in Manitoba. Can J Infect Dis Med Microbiol 2001;12:149–52.
38.Public Health Agency of Canada. Results of surveillance of methicillin-resistant Staphylococcus aureus from 1995 to 2009. Ottawa (ON): Canadian Nosocomial Infection Surveillance Program (CNISP); 2011.
39.McGeer, A, Fleming, C, Green, K, et al. Antimicrobial resistance in common hospital pathogens in Ontario. QMPLS News 2006;104:110.
40.Canadian Nosocomial Infection Surveillance Program. Surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals - a report update from the Canadian Nosocomial Infection Surveillance Program. Can Commun Dis Rep 2005;31:3340.
41.Schmitz, GR, Bruner, D, Pitotti, R, et al. Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for communityassociated methicillin-resistant Staphylococcus aureus infection. Ann Emerg Med 2010;56:283–7, doi:10.1016/j.annemergmed.2010.03.002.
42.Frazee, BW, Lynn, J, Charlebois, ED, et al. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005;45:311–20, doi:10.1016/j.annemergmed.2004.10.011.
43.Lee, MC, Rios, AM, Aten, MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004;23:123–7, doi:10.1097/01.inf.0000109288.06912.21.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Canadian Journal of Emergency Medicine
  • ISSN: -
  • EISSN: 1481-8035
  • URL: /core/journals/canadian-journal-of-emergency-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed